Immunotherapy for biliary tract cancer: Current status and perspectives / 临床肝胆病杂志

ABSTRACT

Biliary tract cancer (BTC) is rare in clinical practice and is difficult to diagnose in the early stage, and conventional treatment methods have unsatisfactory clinical effects. As a new research hotspot at present, immunotherapy has been proven to have a promising future in the treatment of a variety of cancers. At present, various immunotherapies, including immunological checkpoint inhibitors, adoptive immune cell therapy, and tumor vaccine therapy, have been applied in the clinical trials of BTC. This article briefly describes the current status and perspectives of immunotherapy in the treatment of BTC.